SWI/SNF chromatin remodeling factor BAF60b restrains inflammatory diseases by affecting regulatory T cell migration
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Xiaoqian Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology and Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 311100, C…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Cell Movement, Mice, Inbred C57BL, Inflammation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Regulatory T (Treg) cells play a critical regulatory role in the immune system by suppressing excessive immune responses and maintaining immune balance. The effective migration of Treg cells is crucial for controlling the development and progression of inflammatory diseases. However, the mechanisms responsible for directing Treg cells into the inflammatory tissue remain incompletely elucidated. In this study, we identified BAF60b, a subunit of switch/sucrose nonfermentable (SWI/SNF) chromatin remodeling complexes, as a positive regulator of Treg cell migration that inhibits the progression of inflammation in experimental autoimmune encephalomyelitis (EAE) and colitis animal models. Mechanistically, transcriptome and genome-wide chromatin-landscaped analyses demonstrated that BAF60b interacts with the transcription factor RUNX1 to promote the expression of CCR9 on Treg cells, which in turn affects their ability to migrate to inflammatory tissues. Our work provides insights into the essential role of BAF60b in regulating Treg cell migration and its impact on inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology and Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 311100, China; Zhejiang University School of Medicine, Hangzhou 310058, China.
- Laboratory Animal Center, Zhejiang University, Hangzhou 310058, China.
- Zhejiang University School of Medicine, Hangzhou 310058, China.
- Co-Facility Center, Zhejiang University School of Medicine, Hangzhou 310058, China.
- Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311100, China; Zhejiang University School of Medicine, Hangzhou 310058, China.
- Zhejiang University School of Medicine, Hangzhou 310058, China; Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Haining 314400, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Liu, X., Liu, K., Wang, Y., Meng, X., Wang, Q., Tao, S., Xu, Q., Shen, X., Gao, X., Hong, S., Jin, H., Wang, J. Q., Wang, D., Lu, L., Meng, Z., & Wang, L. (2024). SWI/SNF chromatin remodeling factor BAF60b restrains inflammatory diseases by affecting regulatory T cell migration. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114458
Vancouver
Liu X, Liu K, Wang Y, Meng X, Wang Q, Tao S, et al. SWI/SNF chromatin remodeling factor BAF60b restrains inflammatory diseases by affecting regulatory T cell migration. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114458
BibTeX
@article{Liu2024,
author = {Liu, Xiaoqian and Liu, Kuai and Wang, Yuxi and Meng, Xiaoyu and Wang, Qianqian and Tao, Sijue and Xu, Qianying and Shen, Xin and Gao, Xianzhi and Hong, Shenghui and Jin, Huihui and Wang, James Q and Wang, Di and Lu, Linrong and Meng, Zhuoxian and Wang, Lie},
title = {SWI/SNF chromatin remodeling factor BAF60b restrains inflammatory diseases by affecting regulatory T cell migration},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114458}
}
EUVIMED